ATM- and ATR-Mediated Phosphorylation of XRCC3 Regulates DNA Double-Strand Break-Induced Checkpoint Activation and Repair

REFERENCES

• Ciccia A, Elledge SJ. 2010. The DNA damage response: making it safe to play with knives. Mol. Cell 40:179–204.
   PubMed Web of Science ®Google Scholar
• Jackson SP, Bartek J. 2009. The DNA-damage response in human biology and disease. Nature 461:1071–1078.
   PubMed Web of Science ®Google Scholar
• Kastan MB, Bartek J. 2004. Cell-cycle checkpoints and cancer. Nature 432:316–323.
   PubMed Web of Science ®Google Scholar
• Lavin MF. 2008. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat. Rev. Mol. Cell Biol. 9:759–769.
   PubMed Web of Science ®Google Scholar
• O'Driscoll M, Jeggo PA. 2006. The role of double-strand break repair—insights from human genetics. Nat. Rev. Genet. 7:45–54.
   PubMed Web of Science ®Google Scholar
• Shiloh Y. 2003. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer 3:155–168.
   PubMed Web of Science ®Google Scholar
• Cimprich KA, Cortez D. 2008. ATR: an essential regulator of genome integrity. Nat. Rev. Mol. Cell Biol. 9:616–627.
   PubMed Web of Science ®Google Scholar
• Flynn RL, Zou L. 2011. ATR: a master conductor of cellular responses to DNA replication stress. Trends Biochem. Sci. 36:133–140.
   PubMed Web of Science ®Google Scholar
• Lavin MF. 2007. ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks. Oncogene 26:7749–7758.
   PubMed Web of Science ®Google Scholar
• Thompson LH. 2012. Recognition, signaling, and repair of DNA double-strand breaks produced by ionizing radiation in mammalian cells: the molecular choreography. Mutat. Res. 751:158–246.
   PubMed Web of Science ®Google Scholar
• Traven A, Heierhorst J. 2005. SQ/TQ cluster domains: concentrated ATM/ATR kinase phosphorylation site regions in DNA-damage-response proteins. Bioessays 27:397–407.
   PubMed Web of Science ®Google Scholar
• Somyajit K, Subramanya S, Nagaraju G. 2010. RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer. Carcinogenesis 31:2031–2038.
   PubMed Web of Science ®Google Scholar
• Suwaki N, Klare K, Tarsounas M. 2011. RAD51 paralogs: roles in DNA damage signalling, recombinational repair and tumorigenesis. Semin. Cell Dev. Biol. 22:898–905.
   PubMed Web of Science ®Google Scholar
• Chun J, Buechelmaier ES, Powell SN. 2013. Rad51 paralog complexes BCDX2 and CX3 act at different stages in the BRCA1-BRCA2-dependent homologous recombination pathway. Mol. Cell. Biol. 33:387–395.
   PubMed Web of Science ®Google Scholar
• Qing Y, Yamazoe M, Hirota K, Dejsuphong D, Sakai W, Yamamoto KN, Bishop DK, Wu X, Takeda S. 2011. The epistatic relationship between BRCA2 and the other RAD51 mediators in homologous recombination. PLoS Genet. 7:e1002148. doi:10.1371/journal.pgen.1002148.
   PubMedGoogle Scholar
• Nagaraju G, Hartlerode A, Kwok A, Chandramouly G, Scully R. 2009. XRCC2 and XRCC3 regulate the balance between short- and long-tract gene conversions between sister chromatids. Mol. Cell. Biol. 29:4283–4294.
   PubMed Web of Science ®Google Scholar
• Nagaraju G, Odate S, Xie A, Scully R. 2006. Differential regulation of short- and long-tract gene conversion between sister chromatids by Rad51C. Mol. Cell. Biol. 26:8075–8086.
   PubMed Web of Science ®Google Scholar
• Griffin CS, Simpson PJ, Wilson CR, Thacker J. 2000. Mammalian recombination-repair genes XRCC2 and XRCC3 promote correct chromosome segregation. Nat. Cell Biol. 2:757–761.
   PubMed Web of Science ®Google Scholar
• Rodrigue A, Coulombe Y, Jacquet K, Gagne JP, Roques C, Gobeil S, Poirier G, Masson JY. 29 October 2012. The RAD51 paralogs ensure cellular protection against mitotic defects and aneuploidy. J. Cell Sci. [Epub ahead of print.] doi:10.1242/jcs.114595.
   PubMedGoogle Scholar
• Tarsounas M, Munoz P, Claas A, Smiraldo PG, Pittman DL, Blasco MA, West SC. 2004. Telomere maintenance requires the RAD51D recombination/repair protein. Cell 117:337–347.
   PubMedGoogle Scholar
• Compton SA, Choi JH, Cesare AJ, Ozgur S, Griffith JD. 2007. Xrcc3 and Nbs1 are required for the production of extrachromosomal telomeric circles in human alternative lengthening of telomere cells. Cancer Res. 67:1513–1519.
   PubMedGoogle Scholar
• Oganesian L, Karlseder J. 2011. Mammalian 5′ C-rich telomeric overhangs are a mark of recombination-dependent telomere maintenance. Mol. Cell 42:224–236.
   PubMed Web of Science ®Google Scholar
• Wang RC, Smogorzewska A, de Lange T. 2004. Homologous recombination generates T-loop-sized deletions at human telomeres. Cell 119:355–368.
   PubMed Web of Science ®Google Scholar
• Badie S, Liao C, Thanasoula M, Barber P, Hill MA, Tarsounas M. 2009. RAD51C facilitates checkpoint signaling by promoting CHK2 phosphorylation. J. Cell Biol. 185:587–600.
   PubMed Web of Science ®Google Scholar
• Meindl A, Hellebrand H, Wiek C, Erven V, Wappenschmidt B, Niederacher D, Freund M, Lichtner P, Hartmann L, Schaal H, Ramser J, Honisch E, Kubisch C, Wichmann HE, Kast K, Deissler H, Engel C, Muller-Myhsok B, Neveling K, Kiechle M, Mathew CG, Schindler D, Schmutzler RK, Hanenberg H. 2010. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat. Genet. 42:410–414.
   PubMed Web of Science ®Google Scholar
• Somyajit K, Subramanya S, Nagaraju G. 2012. Distinct roles of FANCO/RAD51C protein in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility. J. Biol. Chem. 287:3366–3380.
   PubMed Web of Science ®Google Scholar
• Vaz F, Hanenberg H, Schuster B, Barker K, Wiek C, Erven V, Neveling K, Endt D, Kesterton I, Autore F, Fraternali F, Freund M, Hartmann L, Grimwade D, Roberts RG, Schaal H, Mohammed S, Rahman N, Schindler D, Mathew CG. 2010. Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat. Genet. 42:406–409.
   PubMed Web of Science ®Google Scholar
• Matsuoka S, Ballif BA, Smogorzewska A, McDonald ERIII, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, Shiloh Y, Gygi SP, Elledge SJ. 2007. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316:1160–1166.
   PubMed Web of Science ®Google Scholar
• Puget N, Knowlton M, Scully R. 2005. Molecular analysis of sister chromatid recombination in mammalian cells. DNA Repair (Amst.) 4:149–161.
   PubMedGoogle Scholar
• Lou Z, Minter-Dykhouse K, Wu X, Chen J. 2003. MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways. Nature 421:957–961.
   PubMedGoogle Scholar
• Wu L, Luo K, Lou Z, Chen J. 2008. MDC1 regulates intra-S-phase checkpoint by targeting NBS1 to DNA double-strand breaks. Proc. Natl. Acad. Sci. U. S. A. 105:11200–11205.
   PubMed Web of Science ®Google Scholar
• Gildemeister OS, Sage JM, Knight KL. 2009. Cellular redistribution of Rad51 in response to DNA damage: novel role for Rad51C. J. Biol. Chem. 284:31945–31952.
   PubMed Web of Science ®Google Scholar
• Petermann E, Orta ML, Issaeva N, Schultz N, Helleday T. 2010. Hydroxyurea-stalled replication forks become progressively inactivated and require two different RAD51-mediated pathways for restart and repair. Mol. Cell 37:492–502.
   PubMed Web of Science ®Google Scholar
• Lio YC, Schild D, Brenneman MA, Redpath JL, Chen DJ. 2004. Human Rad51C deficiency destabilizes XRCC3, impairs recombination, and radiosensitizes S/G2-phase cells. J. Biol. Chem. 279:42313–42320.
   PubMed Web of Science ®Google Scholar
• Jazayeri A, Falck J, Lukas C, Bartek J, Smith GC, Lukas J, Jackson SP. 2006. ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat. Cell Biol. 8:37–45.
   PubMed Web of Science ®Google Scholar
• Myers JS, Cortez D. 2006. Rapid activation of ATR by ionizing radiation requires ATM and Mre11. J. Biol. Chem. 281:9346–9350.
   PubMed Web of Science ®Google Scholar
• Petermann E, Helleday T. 2010. Pathways of mammalian replication fork restart. Nat. Rev. Mol. Cell Biol. 11:683–687.
   PubMed Web of Science ®Google Scholar
• Yuan SS, Chang HL, Lee EY. 2003. Ionizing radiation-induced Rad51 nuclear focus formation is cell cycle-regulated and defective in both ATM(-/-) and c-Abl(-/-) cells. Mutat. Res. 525:85–92.
   PubMed Web of Science ®Google Scholar
• Jensen RB, Carreira A, Kowalczykowski SC. 2010. Purified human BRCA2 stimulates RAD51-mediated recombination. Nature 467:678–683.
   PubMed Web of Science ®Google Scholar
• Falck J, Mailand N, Syljuasen RG, Bartek J, Lukas J. 2001. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410:842–847.
   PubMed Web of Science ®Google Scholar
• Xu B, Kim S, Kastan MB. 2001. Involvement of BRCA1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol. Cell. Biol. 21:3445–3450.
   PubMed Web of Science ®Google Scholar
• Buscemi G, Savio C, Zannini L, Micciche F, Masnada D, Nakanishi M, Tauchi H, Komatsu K, Mizutani S, Khanna K, Chen P, Concannon P, Chessa L, Delia D. 2001. Chk2 activation dependence on Nbs1 after DNA damage. Mol. Cell. Biol. 21:5214–5222.
   PubMed Web of Science ®Google Scholar
• Esashi F, Christ N, Gannon J, Liu Y, Hunt T, Jasin M, West SC. 2005. CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair. Nature 434:598–604.
   PubMed Web of Science ®Google Scholar
• Schlacher K, Christ N, Siaud N, Egashira A, Wu H, Jasin M. 2011. Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11. Cell 145:529–542.
   PubMed Web of Science ®Google Scholar
• Schlacher K, Wu H, Jasin M. 2012. A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2. Cancer Cell 22:106–116.
   PubMed Web of Science ®Google Scholar
• Moldovan GL, D'Andrea AD. 2012. To the rescue: the Fanconi anemia genome stability pathway salvages replication forks. Cancer Cell 22:5–6.
   PubMedGoogle Scholar
• Ying S, Hamdy FC, Helleday T. 2012. Mre11-dependent degradation of stalled DNA replication forks is prevented by BRCA2 and PARP1. Cancer Res. 72:2814–2821.
   PubMed Web of Science ®Google Scholar
• Bussen W, Raynard S, Busygina V, Singh AK, Sung P. 2007. Holliday junction processing activity of the BLM-Topo IIIalpha-BLAP75 complex. J. Biol. Chem. 282:31484–31492.
   PubMedGoogle Scholar
• Otsuki M, Seki M, Inoue E, Yoshimura A, Kato G, Yamanouchi S, Kawabe Y, Tada S, Shinohara A, Komura J, Ono T, Takeda S, Ishii Y, Enomoto T. 2007. Functional interactions between BLM and XRCC3 in the cell. J. Cell Biol. 179:53–63.
   PubMedGoogle Scholar
• Loveday C, Turnbull C, Ramsay E, Hughes D, Ruark E, Frankum JR, Bowden G, Kalmyrzaev B, Warren-Perry M, Snape K, Adlard JW, Barwell J, Berg J, Brady AF, Brewer C, Brice G, Chapman C, Cook J, Davidson R, Donaldson A, Douglas F, Greenhalgh L, Henderson A, Izatt L, Kumar A, Lalloo F, Miedzybrodzka Z, Morrison PJ, Paterson J, Porteous M, Rogers MT, Shanley S, Walker L, Eccles D, Evans DG, Renwick A, Seal S, Lord CJ, Ashworth A, Reis-Filho JS, Antoniou AC, Rahman N. 2011. Germline mutations in RAD51D confer susceptibility to ovarian cancer. Nat. Genet. 43:879–882.
   PubMed Web of Science ®Google Scholar
• Park DJ, Lesueur F, Nguyen-Dumont T, Pertesi M, Odefrey F, Hammet F, Neuhausen SL, John EM, Andrulis IL, Terry MB, Daly M, Buys S, Le Calvez-Kelm F, Lonie A, Pope BJ, Tsimiklis H, Voegele C, Hilbers FM, Hoogerbrugge N, Barroso A, Osorio A, Giles GG, Devilee P, Benitez J, Hopper JL, Tavtigian SV, Goldgar DE, Southey MC. 2012. Rare mutations in XRCC2 increase the risk of breast cancer. Am. J. Hum. Genet. 90:734–739.
   PubMed Web of Science ®Google Scholar